1. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
- Author
-
Anita Niebuhr, Kirsten Fenger, R.B. Barkardottir, B. Ejlertsen, Åke Borg, J.H. Olsen, H.T. Mouridsen, Erik Niebuhr, K.V. Nielsen, S. Klausen, K. Winther, Theresa Larriba Harboe, and Jon Thor Bergthorsson
- Subjects
Oncology ,Adult ,medicine.medical_specialty ,Heterozygote ,endocrine system diseases ,Denmark ,Genes, BRCA1 ,Breast Neoplasms ,Breast cancer ,Germline mutation ,Internal medicine ,Genetics ,medicine ,Cancer Family ,Humans ,Family history ,Mutation frequency ,Age of Onset ,skin and connective tissue diseases ,Genetics (clinical) ,Germ-Line Mutation ,BRCA2 Protein ,Family Health ,Ovarian Neoplasms ,business.industry ,Cancer ,Original Articles ,medicine.disease ,Cancer registry ,Neoplasm Proteins ,Pedigree ,Endocrinology ,Mutation ,Female ,business ,Ovarian cancer ,Transcription Factors - Abstract
INTRODUCTIONA small fraction of breast cancer is the result of germline mutations in theBRCA1 and BRCA2cancer susceptibility genes. Mutation carriers frequently have a positive family history of breast and ovarian cancer, are often diagnosed at a young age, and may have a higher incidence of double or multiple primary breast tumours than breast cancer patients in general.OBJECTIVESTo estimate the prevalence and spectrum of BRCA1 andBRCA2 mutations in young Danish patients affected with bilateral or multifocal breast cancer and to determine the relationship of mutation status to family history of cancer.SUBJECTSFrom the files of the Danish Breast Cancer Cooperative Group (DBCG), we selected 119 breast cancer patients diagnosed before the age of 46 years with either bilateral (n=59) or multifocal (n=61) disease.METHODSDNA from the subjects was screened for BRCA1 andBRCA2 mutations using single strand conformation analysis (SSCA) and the protein truncation test (PTT). Observed and expected cancer incidence in first degree relatives of the patients was estimated using data from the Danish Cancer Registry.RESULTSTwenty four mutation carriers were identified (20%), of whom 13 had aBRCA1 mutation and 11 carried aBRCA2 mutation. Two mutations inBRCA1 were found repeatedly in the material and accounted for seven of the 24 (29%) mutation carriers. The mutation frequency was about equal in patients with bilateral (22%) and multifocal breast cancer (18%). The incidence of breast and ovarian cancer was greatly increased in first degree relatives ofBRCA1 and BRCA2mutation carriers, but to a much lesser degree in relatives of non-carriers. An increased risk of cancer was also noted in brothers of non-carriers.CONCLUSIONSA relatively broad spectrum of germline mutations was observed inBRCA1 and BRCA2and most of the mutations are present in other populations. Our results indicate that a diagnosis of bilateral and multifocal breast cancer is predictive of BRCA1 andBRCA2 mutation status, particularly when combined with information on the patients' age at diagnosis and family history of breast/ovarian cancer.
- Published
- 2001